Sunday, May 10, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Health | How Do We Know The Covid 19 Vaccines Are Safe

How do we know the COVID-19 vaccines are safe?

Different types of COVID-19 vaccines have been authorised and it's possible side effects will differ for each.

By AP
Published Date - 18 February 2021, 04:55 PM
How do we know the COVID-19 vaccines are safe?
Used vaccine vials that contained (L-R) Pfizer-BioNTech, Moderna and AstraZeneca Covid-19 vaccines are pictured at the Skane University Hospital vaccination centre in Malmo, Sweden.
whatsapp facebook twitter telegram

Washington: How do we know the COVID-19 vaccines are safe? Scientists look for safety issues during the testing phase and continue their monitoring as shots roll out around the world.

So far, the only serious warning to emerge is a rare risk of severe allergic reactions.


Different types of COVID-19 vaccines have been authorised and it’s possible side effects will differ for each — although there’s more public data on the vaccines being rolled out in Western countries than elsewhere.

Countries also vary in their vaccine standards, with some allowing the use of shots before final-stage testing involving large numbers of volunteers.

But in the U.S., Britain and European Union, regulators required any vaccine to be tested in tens of thousands of people before distribution. So far, the U.S. is using shots from Pfizer and Moderna, while Britain and Europe have cleared those plus the AstraZeneca vaccine.

Those companies’ large studies found that common side effects were minor and typical of the immune system revving up: soreness in the arm, fever and flu-like symptoms including fatigue, chills and headache.

But since extremely rare problems might not turn up even in large tests, the vaccines still are being monitored. The U.S. and British governments and the European Medicines Agency track reports filed by health workers and the public about suspected side effects. Extra scrutiny in the U.S. includes tracking insurance claims for red flags. And U.S. vaccine recipients can sign up for a program that sends text messages to see if they’re feeling side effects.
Those checks are proving reassuring.

People are supposed to wait around for a short time after vaccination in case they have a severe allergic reaction, called anaphylaxis. Such incidents so far have been rare, with between 2 and 5 anaphylaxis reports for every million vaccine doses in the first weeks of U.S. inoculations, according to the Centers for Disease Control and Prevention.

Officials expected to receive reports of health problems, even deaths, that occur just by chance in the days or weeks after vaccination, given the huge numbers of people, including the frail elderly, getting inoculated.

Deaths and other serious events are investigated to see if the vaccine played a role. Authorities consider the person’s overall health and how often the reported condition occurs without vaccination. With more than 52 million vaccine doses administered in the U.S. by mid-February, the CDC said it hasn’t detected any patterns in deaths that signal a safety problem.

  • Follow Us :
  • Tags
  • anaphylaxis
  • AstraZeneca
  • Covid-19
  • COVID-19 vaccine

Related News

  • Digital learning reshapes education, offers flexible and personalised learning paths

    Digital learning reshapes education, offers flexible and personalised learning paths

  • AstraZeneca collaborates with Telangana health dept for AI lung screening

    AstraZeneca collaborates with Telangana health dept for AI lung screening

  • India’s medical devices industry set to triple by 2030

    India’s medical devices industry set to triple by 2030

  • Indian-American scientist Vinay Prasad quits FDA role again amid pharma clashes

    Indian-American scientist Vinay Prasad quits FDA role again amid pharma clashes

Latest News

  • Dinesh Karthik backs RCB to bounce back against Mumbai Indians in crucial clash

    59 seconds ago
  • Shreya Ghoshal gets emotional Mother’s Day surprise from team

    7 mins ago
  • Jammu and Kashmir police inducts 4,000 recruits into technical policing

    14 mins ago
  • Stalin rebuts Vijay’s ’empty treasury’ claim in Tamil Nadu

    21 mins ago
  • ‘Johny Johny yes papa’ teaches children to lie, says UP minister

    34 mins ago
  • Bowlers must innovate to survive in ultra-aggressive T20 era, says Shane Bond

    38 mins ago
  • ‘Thalapathy’ no more: Vijay steps into role of ‘Muthalvan’

    42 mins ago
  • Deeply honoured to welcome PM at our residence: Chandrababu Naidu

    11 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam